|
|
|
|
What Do Legal Challenges on Gene Patents Mean for Neurology?
What Do Legal Challenges on Gene...ARTICLE LINKS: for (var i Neurology Today:Volume 9(13)2 July 2009p 25-26 What Do Legal Challenges on Gene Patents Mean for Neurology? [LEGAL-EASE] PHILLIPS, LISA A legal challenge to the patent on two...
|
|
|
Myriad Genetics Spins Off Research, Pharmaceutical Business
Myriad Genetics to claim approximately $400 million in tax deductions Myriad Genetics has completed the spin off of Myriad Pharmaceuticals.Also, the company has received a Private Letter Ruling from the Internal Revenue...
|
|
|
Interleukin Genetics to sell AJG Brands unit
Interleukin Genetics Inc., a Waltham-based genetic biomarker test maker, plans to sell AJG Brands Inc.for $4.6 million to Nutraceutical Corp. subsidiary Pep Products Inc. Interleukin plans to use the profits of the sale to...
|
|
|
Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize
- Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation.She is being honored with the prestigious international award for...
|
|
|
Genetics study shows influences of nature and nurture
Practise, practise, practise might get you to Carnegie Hall, but for aspiring musicians, there's new evidence that genes may influence one's ability to get there, as well.Perfect pitch, also known as absolute pitch, is the rare ability to...
|
|
|
Study Led By Stanford Scientists Links Schizophrenia To Chromosome Region For The First Time
Stanford University School of Medicine scientists have played a major role in an international effort that has shown, for the first time, that modern genetic technologies can solve the riddle of how gene variations lead to schizophrenia.
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
Companies mentioned in this article: Interleukin Genetics, Inc.WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to...
|
|
|
Myriad Genetics spins-off Myriad Pharmaceuticals
(Datamonitor Financial Deals Tracker via COMTEX) -- MYRX | Quote | Chart | News | PowerRating -- Myriad Genetics, Inc., a US-based biopharmaceutical company focused on pervasive diseases, has spun-out its research and pharmaceutical...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
Latest Health News WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James
Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to Pep Products, Inc., a subsidiary of Nutraceutical...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
|
|
Interleukin Genetics Announces Strategic Divestment of Alan James Group
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.(NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to...
|
